Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Agios Pharmaceuticals Ord Shs (NQ: AGIO)
42.15 USD  -1.09 (-2.52%)
Official Closing Price  /  Updated: 5:55 PM EDT, Aug 10, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,094,138
Open 43.14
Bid (Size) 40.69 (1)
Ask (Size) 42.51 (2)
Prev. Close 43.24
Today's Range 41.25 - 43.27
52wk Range 27.77 - 56.74
Shares Outstanding 57,605,621
Dividend Yield N/A
Performance
YTD
-11.30%
-11.30%
1 Month
-20.32%
-20.32%
3 Month
-4.49%
-4.49%
6 Month
-13.20%
-13.20%
1 Year
-1.54%
-1.54%
Top News
More News
Agios to Present at the Virtual Canaccord 40th Annual Growth Conference on Thursday, August 13, 2020
from GlobeNewswire News Releases
Agios Reports Business Highlights and Second Quarter 2020 Financial Results
from GlobeNewswire News Releases
More News
Read More
Agios to Webcast Conference Call of Second Quarter 2020 Financial Results on July 30, 2020
from GlobeNewswire News Releases
Agios to Present at the BMO 2020 Prescriptions for Success Healthcare Virtual Conference on Tuesday, June 23, 2020
from GlobeNewswire News Releases
Chart of the Day: Agios Pharmaceuticals (AGIO)
category NASDAQ:AGIO
from StockNews.com
Agios and Royalty Pharma Announce $255 Million Purchase Agreement for IDHIFA® Royalty
from GlobeNewswire News Releases
Agios Announces Clinical Proof-of-Concept Has Been Established in Phase 1 Study of Mitapivat, First-in Class PKR Activator, in Sickle Cell Disease
from GlobeNewswire News Releases
Agios First-in Class PKR Activator Mitapivat Demonstrates Sustained Hemoglobin Responses in Non-transfusion-dependent α- and β-Thalassemia in Phase 2 Study
from GlobeNewswire News Releases
Agios Pharmaceuticals Inc (AGIO) Q2 2020 Earnings Call Transcript
category Market News , AGIO
from Motley Fool
Agios Pharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating
from Investor's Business Daily
Stocks Showing Improving Market Leadership: Agios Pharmaceuticals Earns 83 RS Rating
from Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.